AMLo Biosciences
0 followers
‌
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.
Industries
Headquarters
Employees
Links
Org chart
Marie Labus
Chief Executive Officer
Marie Labus
Collapse
Penny Lovat
Chief Scientific Officer
Akhtar Husain
Chief Medical Officer
Jane Meaney
Chief Marketing Officer
Philip Sloan
Chief Histopathologist
Sarah Cockman
Quality Assurance & Regulatory Affairs Manager
Grant Richardson
Technical Manager
Catherine Graham
Project Manager
Helen Pearse
Systems Administrator
Robert Smith
Lab Technician
